NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based,
personalized healthcare company, today announced that it will report
financial results for its 2019 first quarter on Thursday, May 9, 2019,
after market close. NantHealth management will host a conference call
that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s
performance.
The conference call will be available to interested parties by dialing
844-309-3709 from the U.S. or Canada, or 281-962-4864 from international
locations, passcode 6159197. The call will be broadcast via the Internet
at www.nanthealth.com.
About NantHealth, Inc.
NantHealth, a member of the NantWorks ecosystem of companies, provides
leading solutions across the continuum of care for physicians, payors,
patients and biopharmaceutical organizations. NantHealth enables the use
of cutting edge data and technology towards the goals of empowering
clinical decision support and improving patient outcomes. NantHealth’s
comprehensive product portfolio combines the latest technology in
molecular analysis (GPS Cancer® and Liquid GPS®),
payor/provider platforms that exchange information in near-real time
(NaviNet and Eviti), and connected care solutions that deliver Medical
Device Interoperability (MDI). NantHealth’s GPS Cancer®
molecular profiling provides comprehensive DNA & RNA tumor-normal
profiling combined with pharmacogenomics analysis. Liquid GPS®
provides non-invasive testing of cfDNA and cfRNA to monitor cancer
mutations and potentially select targeted therapies, chemotherapies, and
immunotherapies. For more information, please visit www.nanthealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190502005254/en/